Cathepsin K: The association between Cathepsin K expression and sphenoid sinus invasion of pituitary adenomas.

[1]  Cheng-Zhi Wang,et al.  Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas , 2016, Medicine.

[2]  L. Duong,et al.  Efficacy of a Cathepsin K Inhibitor in a Preclinical Model for Prevention and Treatment of Breast Cancer Bone Metastasis , 2014, Molecular Cancer Therapeutics.

[3]  A. Heaney.  Management of aggressive pituitary adenomas and pituitary carcinomas , 2014, Journal of Neuro-Oncology.

[4]  Alex Bateman,et al.  MEROPS: the database of proteolytic enzymes, their substrates and inhibitors , 2011, Nucleic Acids Res..

[5]  A. Jensen,et al.  The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: results of a 4-week, double-blind, randomized, controlled trial. , 2010, Clinical breast cancer.

[6]  T. M. Rünger,et al.  Expression and regulation of cathepsin K in skin fibroblasts , 2009, Experimental dermatology.

[7]  Gesine Hansen,et al.  Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival. , 2009, Lung cancer.

[8]  Jun Yao,et al.  Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression , 2008, Clinical Cancer Research.

[9]  V. Castronovo,et al.  A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden. , 2007, Cancer research.

[10]  M. Karsdal,et al.  The Type I Collagen Fragments ICTP and CTX Reveal Distinct Enzymatic Pathways of Bone Collagen Degradation , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  R. Thomas,et al.  Cathepsin K mRNA and Protein Expression in Prostate Cancer Progression , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  J. Kuratsu,et al.  Are Nonfunctioning Pituitary Adenomas Extending into the Cavernous Sinus Aggressive and/or Invasive? , 2001, Neurosurgery.

[13]  Sheila J. Jones,et al.  Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Sloane,et al.  The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. , 1997, Cancer research.